-
Webinar: Multiplexed Lateral Flow Assay DevelopmentWebinarThe applications of lateral flow assays have expanded significantly in a post-pandemic world, with a particular focus on infectious disease and oncology. These two areas remain at the forefront of research and development. To meet market demands and overcome technical challenges, the utilization of multiplexing has become more prevalent in both fields.
-
A Diagnostic Device for Detecting Biomarkers of Organ Injury in SalivaWebinarOrgan injury – arising from diverse causes such as heart attack, chemical exposure, and other factors – induces biochemical changes in the human body that can be directly measured. The ability to detect and quantify relevant biomarkers associated with organ damage without invasive blood collection holds immense value when such events occur outside of a clinical setting.
-
PLGA Nanoparticles – Bridging the Gap from R&D to GMPWhitepaperPoly(lactic-co-glycolic acid) (PLGA) has emerged as a promising material for drug delivery and biomedical applications. Its exceptional biocompatibility, customizable degradation and release properties, and versatility have led to its approval by regulatory bodies like the FDA and EMA.
-
Nanomaterials for cancer nanomedicine: Case studiesWhitepaperCancer nanomedicine has emerged as a highly promising approach for improving the effectiveness and safety of cancer therapy. Nanoparticles have been engineered to selectively target cancer cells, overcome biological barriers, and deliver a wide range of therapeutic payloads including small molecules, nucleic acids, and proteins.
-
Infographic: Adapting Lateral Flow Assays for Nucleic Acid DetectionInfographicLateral flow assays are well-known for their ability to rapidly detect the presence or absence of proteins. Although easy to perform, its widespread adoption for other applications has been limited due to several constraints.